Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes

Client News  | 

Now Let's Get Started

See how SVB makes next happen now for entrepreneurs like you.

Connect with Us